N
Nelson B. Watts
Researcher at University of Cincinnati Academic Health Center
Publications - 215
Citations - 20940
Nelson B. Watts is an academic researcher from University of Cincinnati Academic Health Center. The author has contributed to research in topics: Osteoporosis & Bone density. The author has an hindex of 59, co-authored 209 publications receiving 18999 citations. Previous affiliations of Nelson B. Watts include Emory University & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Cyclical Etidronate in the Treatment of Postmenopausal Osteoporosis: Efficacy and Safety After Seven Years of Treatment
Paul D. Miller,Nelson B. Watts,Angelo A. Licata,Steven T. Harris,Harry K. Genant,Richard D. Wasnich,Philip D. Ross,Rebecca D. Jackson,Mohammed S. Hoseyni,Steven L. Schoenfeld,David J. Valent,Charles H. Chesnut +11 more
TL;DR: Long-term cyclical etidronate is a safe, effective, and well-tolerated treatment for postmenopausal osteoporosis and further gains in spinal bone mass are seen in patients who continue therapy.
Journal ArticleDOI
Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
George T. Tindall,Nelson M. Oyesiku,Nelson B. Watts,Richard V. Clark,James H. Christy,David A. Adams +5 more
TL;DR: The results of transsphenoidal adenomectomy for growth hormone (GH)-secreting pituitary adenomas in acromegaly performed over a 17-year period were analyzed retrospectively to determine which preoperative factors significantly influenced the long-term surgical outcome.
Journal ArticleDOI
Practical Clinical Application of Biochemical Markers of Bone Turnover: Consensus of an Expert Panel
Paul D. Miller,Daniel T. Baran,John P. Bilezikian,Susan L. Greenspan,Robert Lindsay,B. Lawrence Riggs,Nelson B. Watts +6 more
TL;DR: Bone turnover has emerged as powerful tools to aid in managing osteoporosis as discussed by the authors, and has been intensively studied for more than a decade, which can now confidently report their clinical utility in assessing risk of rapid bone loss and fracture, and monitoring therapy in postmenopausal women with or at risk of osteoporeosis.
Journal ArticleDOI
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
William D. Schlaff,Ronald T. Ackerman,Ayman Al-Hendy,David F. Archer,Kurt T. Barnhart,Linda D. Bradley,Bruce R. Carr,Eve C. Feinberg,Sandra Hurtado,Jin Hee Kim,Ran Liu,R. Garn Mabey,Charlotte D. Owens,Alfred N. Poindexter,Elizabeth E. Puscheck,Henry Rodriguez-Ginorio,James A. Simon,Ahmed M. Soliman,Elizabeth A. Stewart,Nelson B. Watts,Ozgul Muneyyirci-Delale +20 more
TL;DR: Elagolix with add-back therapy was effective in reducing heavy menstrual bleeding in women with uterine fibroids and Hypoestrogenic effects of elagolIX, especially decreases in bone mineral density, were attenuated withAdd- back therapy.
Journal ArticleDOI
Bisphosphonates and Osteonecrosis of the Jaw
Nelson B. Watts,Steven T. Harris,Michael R. McClung,John P. Bilezikian,Susan L Greenspan,Marjorie M. Luckey +5 more
TL;DR: This volumes seeks to improve awareness of the condition and the need for increased screening and improved diagnosis of ONJ and explores possible treatment options for ONJ to help guide future areas for research.